The detailed structure of a misfolded protein from a diseased deer could help explain why the disease hasn’t made the leap to humans.

12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the ...

An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...

14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic ...

Alzheimer’s disease and many other neurodegenerative disorders that occur due to age are caused by proteotoxic insults. 3 In ...

Presented full dataset from first-in-human Phase 1a clinical trial demonstrating PMN310 was generally well-tolerated with monthly dosing and that PMN310 demonstrated CSF levels indicative of potential ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...

The fireside chat will take place on November 20, 2024, at 6:00 AM (ET) / 11:00 AM (GMT). A webcast of the fireside chat will be available on the Events Page of AC Immune's website. A replay will be ...

In order to slow the spread of chronic wasting disease, MDC will mandate sampling for all deer harvested this weekend in 43 ...

The Hamilton scientists were able to map a CWD prion, the misfolded protein that causes the deadly brain disease, to the near ...